The New York Times unearths a curious story about increasing health expenses.
It is an interesting problem for free-marketeers. If you have a little-needed product that can be produced for about $50, how do you make money?
Of course, if you raise the price to $28,000, it becomes rather easier to get into the black.
If you have a captive market.
You know who make good captives?
While it looks as if this particular scam has added mere millions to the nation's health care costs, a similar dynamic works with some vaccines (and other low-cost, high-impact nostrums). The public benefit is enormous but it is impossible to achieve it via a market.